Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on recist guidelines: is mri as effective as ct?

HIGHLIGHTS

• who: Panpan Yang from the Department of Radiology, Changhai Hospital of Shanghai, Naval Medical University, No, Changhai Road, Shanghai, China have published the research work: Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT?, in the Journal: (JOURNAL)
• what: The authors investigated the similarities and differences in tumor measurements between CT and MRI before and after NAT for PC based on RECIST 1.1 criteria. The study has compared the difference between the imaging and pathological sizes of tumors after NAT for PC.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.